3R Petroleum S.A. had recently acquired from Petrobras a group of oil fields known as the Macau Polo. This acquisition marks the first time a private equity fund has taken over the operation of an onshore oil field. Starboard Asset will be the managing fund manager of 3R Petroleum, a company set up to manage […]
The group has over 30 years of experience in real estate and is active in Israel, as well as in Europe. The group owns over 375,000 square meters of yielding properties, rented out to over 260 tenants, at approximately 95% occupancy. Recently, GKH - one of the largest, most renowned law firms in Israel - […]
Computers with many apps are installed in almost all devices and objects surrounding us. These technologies interlock today, with the result of complete, multinational networking. Such technical achievements lead to numerous legal questions and areas of conflict. Lawyer Roman Pusep has been dealing with the legal aspects of information technology (IT) for more than 12 […]
Kuwait should reconsider its arbitration laws in order to fall in line with the rest of the initiatives adopted by its neighbouring GCC member states. This will enhance Kuwait’s attractiveness for foreign direct investment. The Current Arbitration Law Scene in Kuwait Article 173 of the Procedures Law confers the parties the power to submit their […]
Speaking to Steven Tal Young, he reveals the importance of non-disclosures in real estate and how the sellers have an obligation to state issues and defects with the property prior to a transaction being finalized. Why has there been a sudden upsurge in non-disclosures in real estate? The 2008 economic downturn in the United States […]
Nonetheless, when construction goes wrong, it can have dire impacts, and often an Expert Witness is needed to determine what exactly went wrong so justice can prevail. Below, Kurt explains the various ways that construction goes wrong and how he assists in such cases. What are the various stages during which construction can go wrong? […]
Biologics are an increasing share of the pharmaceutical market, and many of them are monoclonal antibody drugs. For broad claims to such antibodies, satisfying the written description and enablement requirements is becoming more difficult, as can be seen in an ongoing patent dispute between Amgen and Sanofi for their monoclonal PCSK9 inhibitor antibody drugs for […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent
